Inion Receives 510(k) Marketing Clearance To Sell Its Biodegradable Graft Containment Systems In The USA For Spinal Fusion Procedures

Inion (LSE: IIN), the company focused on the development and commercialisation of novel biodegradable medical implants, announces it has received 510(k) marketing clearance from the US Food and Drug Administration (FDA) for its biodegradable graft containment systems for spinal fusion procedures.

More: continued here

Filed under: Bones on July 22nd, 2008